Company intelligence / Profile preview

3Daughters

Mansfield, Massachusetts, USA3daughtershealth.com ↗

Ownership: Private
Development stage: Preclinical

Overview

3Daughters is developing a novel frameless, non-hormonal magnetic IUD designed to reduce insertion pain—a major barrier to IUD adoption. The product uses three small elliptical magnetic units that self-align in the uterus. Clinical trials are planned for 2025. No clinical results have been reported yet.

Therapeutic areas: Women's Health
Modalities: Device (frameless, non-hormonal intrauterine device)Magnetic device technology
Industry: Implantable Medical Devices

Drug pipeline

1 asset

3D-001

Pre-clinical

Indications: Contraception

Partnerships

Wexford Science & Technology

Beyond the preview

Go deeper on 3Daughters.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3Daughters.

Explore the full profile